Asia Spotlight: Collaboration Key For China Regulatory Reforms, RDPAC Says
Executive Summary
The days when foreign investments were welcomed with open arms in China seem to be gone, and a toughening environment is setting in. Joseph Cho, head of the country's top multinational research-based pharma association, is looking to local partnerships to help pursue regulatory reforms and expand new drug access in a rapidly changing market.